CLINICAL ROLE -
Combating Advancing Cancers With CAR T-Cell Therapy
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Read More